Hemant Surgical Industries Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Hemant Surgical Industries Ltd is ₹ 573.6 as of 30 Oct 15:30 . The P/E Ratio of Hemant Surgical Industries Ltd changed from 12.9 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 39.4 on March 2025 to 44.3 on March 2024 . This represents a CAGR of 1.97% over 6 years The Market Cap of Hemant Surgical Industries Ltd changed from ₹ 104.03 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 3604 crore on March 2025 to ₹ 3135 crore on March 2024 . This represents a CAGR of -2.30% over 6 years The revenue of Hemant Surgical Industries Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Thyrocare Technologies Ltd for the Sep '26 is ₹ 275.24 crore as compare to the Jun '26 revenue of ₹ 244.88 crore. This represent the growth of 12.4% The ebitda of Hemant Surgical Industries Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Thyrocare Technologies Ltd for the Sep '26 is ₹ 48.74 crore as compare to the Jun '26 ebitda of ₹ 82.13 crore. This represent the decline of -40.66% The net profit of Hemant Surgical Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 15.22 crore over 10 quarters. This represents a CAGR of -16.57% The Dividend Payout of Hemant Surgical Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Hemant Surgical Industries Ltd

Hemant Surgical Industries Limited was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Mumbai.
Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai. Company is in the business of Medical Equipment & Supplies in Mumbai.
Its product basket cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables.
In addition, the Company is providing services for maintenance and in running of 5 dialysis centres. The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Hemant Surgical Industries Ltd or Thyrocare Technologies Ltd?

Market cap of Hemant Surgical Industries Ltd is 833 Cr while Market cap of Thyrocare Technologies Ltd is 7,273 Cr

What are the key factors driving the stock performance of Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd?

The stock performance of Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd?

As of November 1, 2026, the Hemant Surgical Industries Ltd stock price is INR ₹573.6. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹457.0.

How do dividend payouts of Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Hemant Surgical Industries Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.